196 related articles for article (PubMed ID: 1700570)
1. Not all insulin secretagogues sensitize pancreatic islets to recombinant human interleukin 1 beta.
Johannesen J; Helqvist S; Nerup J
Acta Endocrinol (Copenh); 1990 Oct; 123(4):445-52. PubMed ID: 1700570
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets.
Buscema M; Vinci C; Gatta C; Rabuazzo MA; Vignen R; Purrello F
Metabolism; 1992 Mar; 41(3):296-300. PubMed ID: 1531861
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures.
Rabinovitch A; Pukel C; Baquerizo H
Endocrinology; 1988 Jun; 122(6):2393-8. PubMed ID: 2453340
[TBL] [Abstract][Full Text] [Related]
4. Human interleukin-1 beta induced stimulation of insulin release from rat pancreatic islets is accompanied by an increase in mitochondrial oxidative events.
Eizirik DL; Sandler S
Diabetologia; 1989 Nov; 32(11):769-73. PubMed ID: 2687062
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 beta-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methyl xanthine.
Andersen HU; Mauricio D; Karlsen AE; Mandrup-Poulsen T; Nielsen JH; Nerup J
Eur J Endocrinol; 1996 Feb; 134(2):251-9. PubMed ID: 8630528
[TBL] [Abstract][Full Text] [Related]
6. Repetitive exposure of pancreatic islets to interleukin-1 beta. An in vitro model of pre-diabetes?
Helqvist S; Zumsteg UW; Spinas GA; Palmer JP; Mandrup-Poulsen T; Egeberg J; Nerup J
Autoimmunity; 1991; 10(4):311-8. PubMed ID: 1772965
[TBL] [Abstract][Full Text] [Related]
7. Different effects of glucose and glyburide on insulin secretion in rat pancreatic islets pre-exposed to interleukin-1 beta. Possible involvement of K+ and Ca2+ channels.
Buscema M; Rabuazzo AM; Vinci C; Caltabiano V; Vigneri R; Purrello F
Diabetologia; 1993 Sep; 36(9):791-6. PubMed ID: 8405748
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.
Rabuazzo AM; Buscema M; Caltabiano V; Anello M; Degano C; Patanè G; Vigneri R; Purrello F
Diabetologia; 1995 Jul; 38(7):779-84. PubMed ID: 7556978
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
Sandler S; Bendtzen K; Eizirik DL; Welsh M
Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
[TBL] [Abstract][Full Text] [Related]
12. Preserved initiatory and potentiatory effect of alpha-ketoisocaproate on insulin release in islets of glucose intolerant rats.
Guenifi A; Abdel-Halim SM; Efendic S; Ostenson CG
Diabetologia; 1998 Nov; 41(11):1368-73. PubMed ID: 9833946
[TBL] [Abstract][Full Text] [Related]
13. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets.
Eizirik DL; Welsh N; Hellerström C
J Clin Endocrinol Metab; 1993 Feb; 76(2):399-403. PubMed ID: 8432782
[TBL] [Abstract][Full Text] [Related]
14. Functional and morphological effects of interleukin-1 beta on the perfused rat pancreas.
Wogensen LD; Kolb-Bachofen V; Christensen P; Dinarello CA; Mandrup-Poulsen T; Martin S; Nerup J
Diabetologia; 1990 Jan; 33(1):15-23. PubMed ID: 2406177
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical release of insulin by adult pig islets in vitro. Recovery after culture in a defined tissue culture medium.
Davalli AM; Bertuzzi F; Socci C; Scaglia L; Gavazzi F; Freschi M; DiCarlo V; Pontiroli AE; Pozza G
Transplantation; 1993 Jul; 56(1):148-54. PubMed ID: 7687394
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 beta effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans-arginine-dependence and relationship to insulin secretion.
Green IC; Delaney CA; Cunningham JM; Karmiris V; Southern C
Diabetologia; 1993 Jan; 36(1):9-16. PubMed ID: 7679657
[TBL] [Abstract][Full Text] [Related]
17. Beta-cell memory to insulin secretagogues: characterization of the time-dependent inhibitory control system in the isolated rat pancreas.
Nesher R; Eylon L; Segal N; Cerasi E
Endocrinology; 1989 Jan; 124(1):142-8. PubMed ID: 2462485
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration.
Sandler S; Bendtzen K; Eizirik DL; Strandell E; Welsh M; Welsh N
Immunol Lett; 1990 Dec; 26(3):245-51. PubMed ID: 2086453
[TBL] [Abstract][Full Text] [Related]
19. Effect of L-asparaginase on insulin secretion from isolated rat islets of Langerhans.
Pou JM; Cervera T; Perez A; Ortiz MA; Arroyo JA
Horm Res; 1991; 35(3-4):155-60. PubMed ID: 1725285
[TBL] [Abstract][Full Text] [Related]
20. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
